Neurotrophic tyrosine kinase receptor (NTRK) is a family of 3 proto-oncogenes including NTRK1, NTRK2, and NTRK3. NTRK gene fusions have been reported in a variety of tumor types, which are involved in biological processes such as neuronal survival, differentiation, and plasticity under physiological circumstances. Recently, the FDA has approved Entrectinib for patients with NTRK fusions, thus testing for NTRK fusions identifies patients who may be candidates for NTRK inhibitor therapy.

• NTRK Datasheet IVDR

• MSDS

CLONE:
IHC707

ISOTYPE:
IgG, kappa (Rab)

HOST SPECIES:
Rabbit

CLONALITY:
Monoclonal

POSITIVE CONTROL:
NTRK fusion + Carcinoma

DILUTION RANGE:


INTENDED USE/REG. STATUS:
IVDR